Reboxetinemesylate
CAS: 71620-89-8
Ref. 3D-FR148959
1g | 865.00 € | ||
50mg | 194.00 € | ||
100mg | 309.00 € | ||
250mg | 473.00 € | ||
500mg | 645.00 € |
Product Information
- (2R)-2-[(R)-(2-ethoxyphenoxy)(phenyl)methyl]morpholine
- (2R)-2-[(R)-(2-ethoxyphenoxy)(phenyl)methyl]morpholine methanesulfonate (1:1)
- (2S)-2-[(S)-(2-ethoxyphenoxy)(phenyl)methyl]morpholine
- (S,S)-2-[(2-ethoxyphenoxy)-phenylmethyl] morpholine
- 2-[(2-Ethoxyphenoxy)(Phenyl)Methyl]Morpholine
- Axs 12
- Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (2R)-rel-
- Norebox
- Prolift
- Reboxitine
- See more synonyms
- Vestra
- rel-(2R)-2-[(R)-(2-Ethoxyphenoxy)phenylmethyl]morpholine
- Reboxetine
Reboxetinemesylate is a prodrug that is converted to reboxetine, the active form of the drug. It has been shown to be effective in the treatment of symptoms related to depression and Parkinson's disease. Reboxetinemesylate has a long-term efficacy due to its long half-life and slow release from plasma proteins. This drug may have drug interactions with other medications, such as hepatic impairment or drugs that are metabolized by CYP450 enzymes. Reboxetinemesylate also has locomotor activity effects on rats, which may be due to dopamine receptor agonist properties. Reboxetinemesylate is not active against bacterial infections, but is used for the treatment of Parkinson's disease and depression.
Chemical properties
Technical inquiry about: 3D-FR148959 Reboxetinemesylate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.